Cancer Cachexia Resources for Healthcare Professionals This educational resource is intended to provide healthcare professionals with the tools to aid in the effective management of cancer cachexia, empowering them to provide the highest standard of care to their patients. This resource has been created in coordination with the American Cancer Society. Our editorial panel comprises […]
Wednesday, May 21, 2025 at 10:30 AM Eastern Daylight Time.
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer.…
This study explores the role of immunotherapy in improving survival outcomes for patients with resectable lung cancer. Findings suggest that integrating immunotherapy with standard treatments…
The authors compared allogeneic (allo-SCT) with autologous stem cell transplantation (auto-SCT) in patients who relapsed after first-line auto-SCT. The results showed significantly better progression…
Adult patients (N = 81,128; median follow-up, 76.8 months), diagnosed with Stage III or IV breast cancer in the National Cancer Database (2010–2019) were stratified as IIIA/B/C…
In patients with advanced non–small cell lung cancer with PD-L1 ≥50% who had clinically stable brain metastases at baseline, first-line cemiplimab monotherapy improved survival and…
This review details the recent major advances in the understanding and therapy of adult acute lymphoblastic leukemia.
In this issue of Cancer, Cecchini et al. report findings from a phase 2, open-label trial of olaparib in 30 patients with advanced cholangiocarcinoma with isocitrate…
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, “Cancer Statistics, 2025” reports that…
Overall, much progress was made in 2024 in the realm of neoadjuvant immunotherapy including the firm establishment of neoadjuvant immunotherapy as superior to only adjuvant…
